ArcherDX, LLC v. QIAGEN Sciences, LLC
| ARCHERDX, LLC and THE GENERAL HOSPITAL CORPORATION, dba Massachusetts General Hospital |
| QIAGEN SCIENCES, LLC, QIAGEN LLC, fka QIAGEN, Inc., QIAGEN BEVERLY, LLC, fka QIAGEN Beverly, Inc., QIAGEN GAITHERSBURG, LLC, fka QIAGEN Gaithersburg, Inc., QIAGEN GMBH, QIAGEN N.V. and JONATHAN ARNOLD |
| 23-2379 |
| September 12, 2023 |
| U.S. Court of Appeals, Federal Circuit |
| Patent Infringement (Fed. Qst.) |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 12, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 2 Note to File: The following cases are consolidated: 23-2350 (Lead) with 23-2379 (Cross-Appeal). The parties must file all documents in the lead appeal only. [949528] [23-2350, 23-2379] [MMA] [Entered: 09/12/2023 03:15 PM] |
| Filing 1 Appeal docketed. Received: 09/05/2023. [949527] Entry of Appearance due 09/26/2023. Certificate of Interest is due on 09/26/2023. Docketing Statement due 09/26/2023. Appellant/Petitioner's brief is due 11/13/2023. [MMA] [Entered: 09/12/2023 03:10 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
